Taipei, July 19 (CNA) Taiwan has given emergency use authorization (EUA) to a COVID-19 vaccine developed by Taiwan-based Medigen Vaccine Biologics Corp. after a panel of experts felt its data on the vaccine's production of antibodies in Phase 2 trials met local standards.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Argentine garlic, Ukrainian sorghum among items seized at border
03/19/2024 02:54 PM - Business
Taiwan shares close down 0.11%
03/19/2024 02:15 PM - Politics
Vice President-elect Hsiao in the Czech Republic: MOFA
03/19/2024 02:08 PM - Society
Taiwan Railway to add 26 train services for Dajia Mazu Pilgrimage
03/19/2024 12:26 PM - Society
Taiwan headline news
03/19/2024 11:33 AM